BriefCase-Quantification

BriefCase-Quantification is a cloud-based deep-learning artificial intelligence system engineered to automatically measure aortic diameters from contrast-enhanced CT exams, aiding in the assessment of normal and aneurysmal aortas. The system processes DICOM images to provide measurements with a demonstrated mean absolute error of 1.88 mm, affirming its performance comparable to established radiological imaging devices.

BriefCase-Quantification is a cloud-based software system developed by Aidoc Medical, Ltd., designed for analyzing contrast-enhanced CT exams of the aorta in adults and transitional adolescents aged 18 and older. This deep-learning artificial intelligence algorithm assists medical specialists by providing automated aortic diameter measurements at 10 anatomical landmarks, including the maximum diameters of the abdominal, descending, and ascending aorta. It is intended for evaluating both normal and aneurysmal aortas, though it is explicitly not indicated for post-operative cases, and its outputs are unofficial, requiring review by a radiologist before clinical decision-making.The system's methodology involves processing DICOM images to generate visual and tabular results, functioning similarly to other medical image processing software. A retrospective, blinded, multicenter study assessed its performance, revealing a mean absolute error of 1.88 mm and a mean difference of 0.1 mm between the algorithm's measurements and ground truth across 212 cases, indicating minimal bias. This evaluation concluded that BriefCase-Quantification's performance is comparable to other existing devices utilized for aortic measurements in radiological imaging, highlighting its potential as a supportive tool in diagnostic workflows.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. What specific deep-learning architecture or model types are utilized by BriefCase-Quantification, and how do they contribute to its measurement accuracy?; Given that the measurements are unofficial and require radiologist review, what is the measured impact of this system on radiologist workflow efficiency and diagnostic turnaround time in a clinical setting?; How does the system perform in complex or challenging cases, such as those with significant calcification, motion artifacts, or atypical aortic anatomies not explicitly classified as aneurysmal or normal?; What are the technical and clinical barriers preventing the BriefCase-Quantification system from being indicated for post-operative aortas, and what future developments might address this limitation?; Beyond the stated measurement accuracy, what are the long-term clinical outcomes or patient management benefits observed from integrating this AI-driven aortic measurement tool into routine practice?